ACXP — Acurx Pharmaceuticals Inc

Acurx Pharmaceuticals Inc (ACXP) is listed on NASDAQ.

ACXP belongs to the HEALTHCARE sector and the BIOTECHNOLOGY industry.

To answer "what is ACXP worth" or "what is happening with Acurx Pharmaceuticals Inc", VAQO shows a live price alongside technical analysis, relevant headlines and what other investors think.

VAQO's learning model reads seven technical indicators — short and long momentum, RSI, volatility, volume ratio, moving-average cross and position in the 52-week range — and turns them into transparent opportunity and risk scores.

What ACXP is

Acurx Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company is headquartered in Staten Island, New York.…

Acurx Pharmaceuticals Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.

It trades on NASDAQ as a common stock.

ACXP size and valuation

At roughly $7.3M, ACXP is a micro-cap.

Earnings per share are negative at -2.67, so there is no meaningful price-to-earnings multiple to quote.

Beta is -2.05: historically it has moved less than the market.

ACXP over the past year

Over the past year ACXP has traded between $1.23 and $8.14, and the current price sits at -2% of that range.

Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.

The 50-day average is $1.41 against a 200-day average of $2.15 — the shorter average sits below the longer one, usually read as a downtrend.

The published analyst target is $17.00, 1,503.8% above it. A target is an aggregate of opinions, not a measurement.

How Acurx Pharmaceuticals Inc (ACXP) is trading

Acurx Pharmaceuticals Inc (ACXP) is up 12.09% at $1.06. A move that large in a single session sits well outside the normal daily range for most stocks.

The session ranged from $1.01 to $1.08 — 6.6% of the share price — and the current price sits at 71% of that range.

It opened at 0% of the daily range and finished at 71% of it: ACXP turned around inside the session, in the buyers' favour.

It opened at $1.01 against a previous close of $0.95 — an opening gap of +6.8%, which almost always comes from information released outside trading hours.

The day's range extended past the previous close ($0.95) on both sides.

Volume ran near 122.7K shares, about $130.0K of stock changing hands.

Traded alongside ACXP

Names traded alongside ACXP in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).

What VAQO's model says about ACXP

Two statistical models run over ACXP inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.

ACXP at a glance

• Symbol: ACXP
• Name: Acurx Pharmaceuticals Inc
• Sector: HEALTHCARE
• Industry: BIOTECHNOLOGY
• Exchange: NASDAQ
• Instrument: Stock

ACXP — frequently asked questions

Traded alongside ACXP

• A — Agilent Technologies Inc
• AAPG — Ascentage Pharma Group International
• AARD — Aardvark Therapeutics Inc
• ABCL — AbCellera Biologics Inc
• ABEO — Abeona Therapeutics Inc
• ABOS — Acumen Pharmaceuticals Inc

← All stocks on VAQO

Last updated: 2026-11-08